Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 mai 2012 08h15 HE | Source: BG Medicine, Inc.

BG Medicine Announces Publication of First Study on Use of Galectin-3 in Selection of Drug Therapy in Heart Failure

WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
14 mai 2012 08h00 HE | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories

WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
09 mai 2012 08h00 HE | Source: BG Medicine, Inc.

BG Medicine Announces First Quarter 2012 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., May 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the first quarter of fiscal year 2012 will be released before market open...
26 mars 2012 07h30 HE | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Important New Galectin-3 Findings Presented at American College of Cardiology's (ACC) 61st Annual Scientific Session & Expo

WALTHAM, Mass., March 26, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today the...
13 mars 2012 08h30 HE | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 and Heart Failure at American College of Cardiology's 61st Annual Scientific Session & Expo

WALTHAM, Mass., March 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today a...
08 mars 2012 07h00 HE | Source: BG Medicine, Inc.

BG Medicine Announces Fourth Quarter and Full Year Fiscal 2011 Results

WALTHAM, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the fourth quarter and the full year ended December 31,...
02 mars 2012 08h00 HE | Source: BG Medicine, Inc.

BG Medicine Announces Fourth Quarter and Fiscal Year 2011 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., March 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the fourth quarter and fiscal year 2011 will be released before market...
29 févr. 2012 08h30 HE | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at Upcoming Cowen Health Care Conference

WALTHAM, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
13 févr. 2012 08h00 HE | Source: BG Medicine, Inc.

BG Medicine Announces Positive Pivotal Validation Study Results for CardioSCORE, a New Diagnostic Blood Test to Identify Individuals at High Risk for Near-term Major Cardiovascular Events

WALTHAM, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, today announced...
13 févr. 2012 07h50 HE | Source: BG Medicine, Inc.

BG Medicine, Inc. Secures $15 Million Loan Facility From GE Capital and Comerica

WALTHAM, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...

Page précédente

Page suivante